Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I don't understand the recent placements at $1.50....
I also don't understand why this trades at 32 cents on the pinks....
I guess there is not much I understand about the price of Zenith (or RVX).